HUMAN GENOME SCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

HUMAN GENOME SCIENCES INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31)

HUMAN GENOME SCIENCES INC reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Deprecated 2012-01-31) of 514.00% for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.

Discontinued › Notes › Compensation Related Costs

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm · last filed 2012-02-28

• HUMAN GENOME SCIENCES INC share-based compensation arrangement by share-based payment award, options, exercisable, weighted average remaining contractual term (deprecated 2012-01-31) for fiscal 2011 was 514.00%.